These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15077165)

  • 21. A novel human ERK phosphatase regulates H-ras and v-raf signal transduction.
    Shin DY; Ishibashi T; Choi TS; Chung E; Chung IY; Aaronson SA; Bottaro DP
    Oncogene; 1997 Jun; 14(22):2633-9. PubMed ID: 9178761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transformation-restoring factor: a low molecular weight secreted factor required for anchorage-independent growth of oncogene-resistant mutant cell lines.
    Yang JJ; Kang JS; Krauss RS
    Oncogene; 1995 Apr; 10(7):1291-9. PubMed ID: 7731679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ral promotes anchorage-independent growth of a human fibrosarcoma, HT1080.
    Yamazaki Y; Kaziro Y; Koide H
    Biochem Biophys Res Commun; 2001 Jan; 280(3):868-73. PubMed ID: 11162603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. K-Ras promotes growth transformation and invasion of immortalized human pancreatic cells by Raf and phosphatidylinositol 3-kinase signaling.
    Campbell PM; Groehler AL; Lee KM; Ouellette MM; Khazak V; Der CJ
    Cancer Res; 2007 Mar; 67(5):2098-106. PubMed ID: 17332339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immortalized fibroblasts from NF-kappaB RelA knockout mice show phenotypic heterogeneity and maintain increased sensitivity to tumor necrosis factor alpha after transformation by v-Ras.
    Gapuzan ME; Schmah O; Pollock AD; Hoffmann A; Gilmore TD
    Oncogene; 2005 Sep; 24(43):6574-83. PubMed ID: 16027734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissociation of ras oncogene-induced gene expression and anchorage-independent growth in a series of somatic cell mutants.
    Feinleib JL; Krauss RS
    Mol Carcinog; 1996 Jul; 16(3):139-48. PubMed ID: 8688149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stepwise neoplastic transformation of a telomerase immortalized fibroblast cell line.
    Zongaro S; de Stanchina E; Colombo T; D'Incalci M; Giulotto E; Mondello C
    Cancer Res; 2005 Dec; 65(24):11411-8. PubMed ID: 16357149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downstream of Crk adaptor signaling pathway: activation of Jun kinase by v-Crk through the guanine nucleotide exchange protein C3G.
    Tanaka S; Ouchi T; Hanafusa H
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2356-61. PubMed ID: 9122199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Ras-MAPK pathway downregulates Caveolin-1 in rodent fibroblast but not in human fibroblasts: implications in the resistance to oncogene-mediated transformation.
    Sasai K; Kakumoto K; Hanafusa H; Akagi T
    Oncogene; 2007 Jan; 26(3):449-55. PubMed ID: 16832346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rap1 mutants with increased affinity for the guanine-nucleotide exchange factor C3G.
    Shi S; Noda M; Kitayama H
    Oncogene; 2004 Nov; 23(54):8711-9. PubMed ID: 15480424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The association of CRKII with C3G can be regulated by integrins and defines a novel means to regulate the mitogen-activated protein kinases.
    Buensuceso CS; O'Toole TE
    J Biol Chem; 2000 Apr; 275(17):13118-25. PubMed ID: 10777617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncogenic Ras-mediated downregulation of Gadd153/CHOP is required for Ras-induced cellular transformation.
    Rong R; Montalbano J; Jin W; Zhang J; Garling M; Sheikh MS; Huang Y
    Oncogene; 2005 Jul; 24(30):4867-72. PubMed ID: 15870698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Signalling to actin: role of C3G, a multitasking guanine-nucleotide-exchange factor.
    Radha V; Mitra A; Dayma K; Sasikumar K
    Biosci Rep; 2011 Aug; 31(4):231-44. PubMed ID: 21366540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of cell growth by lovastatin is independent of ras function.
    DeClue JE; Vass WC; Papageorge AG; Lowy DR; Willumsen BM
    Cancer Res; 1991 Jan; 51(2):712-7. PubMed ID: 1985788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncogenic Ras, but not (V600E)B-RAF, protects from cholesterol depletion-induced apoptosis through the PI3K/AKT pathway in colorectal cancer cells.
    Calleros L; Sánchez-Hernández I; Baquero P; Toro MJ; Chiloeches A
    Carcinogenesis; 2009 Oct; 30(10):1670-7. PubMed ID: 19700418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of cytokinesis and akt phosphorylation by chaetoglobosin K in ras-transformed epithelial cells.
    Matesic DF; Villio KN; Folse SL; Garcia EL; Cutler SJ; Cutler HG
    Cancer Chemother Pharmacol; 2006 Jun; 57(6):741-54. PubMed ID: 16254733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncogenic Ras upregulates NADPH oxidase 1 gene expression through MEK-ERK-dependent phosphorylation of GATA-6.
    Adachi Y; Shibai Y; Mitsushita J; Shang WH; Hirose K; Kamata T
    Oncogene; 2008 Aug; 27(36):4921-32. PubMed ID: 18454176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RhoE inhibits cell cycle progression and Ras-induced transformation.
    Villalonga P; Guasch RM; Riento K; Ridley AJ
    Mol Cell Biol; 2004 Sep; 24(18):7829-40. PubMed ID: 15340047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple aspects of the phenotype of mammary epithelial cells transformed by expression of activated M-Ras depend on an autocrine mechanism mediated by hepatocyte growth factor/scatter factor.
    Zhang KX; Ward KR; Schrader JW
    Mol Cancer Res; 2004 Apr; 2(4):242-55. PubMed ID: 15140946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncogenic Ras blocks transforming growth factor-beta-induced cell-cycle arrest by degradation of p27 through a MEK/Erk/SKP2-dependent pathway.
    Schepers H; Wierenga AT; Eggen BJ; Vellenga E
    Exp Hematol; 2005 Jul; 33(7):747-57. PubMed ID: 15963850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.